Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Cardiff Oncology (CRDF) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 6 quarters since 2020. Compare with CRDF stock chart to see long term trends.

CRDF stock compared to

CRDF Income Statement

Revenue, Net:68000
Revenue Per Share:0
Selling, General & Admin Expense:2838000
Research & Development Expense:4119000
Total Operating Expenses:6957000
Operating Income:-6889000
Net Income:-6763000
Earnings Per Share, Basic:-0.17
Shares Outstanding, Basic Avg:39552129

CRDF Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:109000
Change in Accounts Receiveable:67000
Net Cash from Operations:-4301000
Net Cash from Financing Activities:19225000
Property, Plant & Equipment Purchases:null
Net Cash from Investing Activities:-19005000
Net Change in Cash & Equivalents:-4081000

CRDF Balance Sheet

Cash and Cash Equivalents:140100000
Short-Term Investments:129470000
Accounts Receivable, Net:308000
Total Current Assets:142871000
Property, Plant & Equipment, Net:422000
Total Assets:143734000
Accounts Payable:543000
Total Short-Term Liabilities:4579000
Total Liabilities:4816000

Insider Trading

Change
Value
Transaction
SEC Form 4
PACE GARY W   Director
30,000 sh at $7
$202,500
Buy
Levine James E.   Chief Financial Officer
30,000 sh at $6
$194,000
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Eventide Asset Management, LLC
3,575,834 sh
1,792,346 sh
100%
$23,779
$7,264
Janus Henderson Group Plc
3,151,167 sh
213,985 sh
7%
$20,954
-$6,233
Blackrock Inc.
2,359,983 sh
1,823,225 sh
340%
$15,694
$10,724
Caxton Corp
2,343,333 sh
228,493 sh
11%
$15,583
-$4,000
Vanguard Group Inc
1,646,044 sh
72,134 sh
5%
$10,946
-$3,629
Avidity Partners Management Lp
1,395,000 sh
-1,052,700 sh
-43%
$9,277
-$13,389
Corriente Advisors, LLC
1,383,500 sh
-1,401,910 sh
-50%
$9,200
-$16,593
Citadel Advisors LLC
1,183,550 sh
1,121,950 sh
1821%
$7,870
$7,300
Octagon Capital Advisors LP
982,753 sh
332,753 sh
51%
$6,535
$516
Artal Group S.A.
750,000 sh
 
$4,988
Two Sigma Investments, Lp
708,668 sh
-16,291 sh
-2%
$4,713
-$2,000
Two Sigma Advisers, Lp
665,200 sh
79,300 sh
14%
$4,424
-$1,001
Franklin Resources Inc
618,600 sh
-21 sh
0%
$4,114
-$1,614
Geode Capital Management, LLC
514,981 sh
306,526 sh
147%
$3,424
$1,494
Altium Capital Management Lp
501,878 sh
501,878 sh
NEW
$3,337
$3,337
State Street Corp
494,491 sh
483,535 sh
4413%
$3,288
$3,187
Morgan Stanley
467,461 sh
442,072 sh
1741%
$3,109
$2,874
Morgan Stanley
467,461 sh
442,072 sh
1741%
$3,109
$2,874
Opaleye Management Inc.
463,000 sh
-113,000 sh
-20%
$3,079
-$2,255
Deutsche Bank Ag\
321,622 sh
56,028 sh
21%
$2,139
-$320

Data imported from Cardiff Oncology Inc SEC filings. Check original filings before making any investment decision.